4.6 Article

Rh-catalyzed asymmetric hydrogenation of α- and β-enamido phosphonates: highly enantioselective access to amino phosphonic acids

Journal

ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 20, Issue 45, Pages 8843-8848

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d2ob01419j

Keywords

-

Funding

  1. National Natural Science Foundation of China [22071240, 21772196]

Ask authors/readers for more resources

Catalytic asymmetric hydrogenation of alpha- and beta-enamido phosphonates was achieved using a chiral hybrid phosphine-bicyclic bridgehead phosphoramidite ligand and rhodium metal precursor as the catalyst. The reaction showed high yields (96-99%) and high enantiomeric excess (<= 99%) with low catalyst loading (S/C up to 10,000) and mild reaction conditions. The hydrogenation reaction selectively occurred at the C = C bond of the enamido phosphate stage without tautomerization to the imine form. Tandem hydrolysis reactions of the hydrogenated products provided alpha- and beta-amino phosphonic acids in high yield, which can serve as versatile building blocks for bioorganic chemistry, medicinal chemistry, and organic synthesis.
Catalytic asymmetric hydrogenation of alpha- and beta-enamido phosphonates was developed using a complex formed in situ through a chiral hybrid phosphine-bicyclic bridgehead phosphoramidite ligand and rhodium metal precursor as the catalyst. This strategy afforded a wide variety of substrates in excellent yield (96-99%) and enantiomeric excess (<= 99%) with very low catalyst loading (S/C up to 10 000) and relatively mild reaction conditions. Further investigations suggested that the hydrogenation reaction occurred only at the C = C bond of the enamido phosphate stage without tautomerization to the imine form. Tandem hydrolysis reactions of hydrogenated products gave the corresponding alpha- and beta-amino phosphonic acids in fairly high yield, which could be multipurpose building blocks for bioorganic chemistry, medicinal chemistry and organic synthesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available